The results of a comparative clinical study with pentoxifylline – a new vasoactive compound – and xanthinol nicotinate in fifty-eight patients suffering from cerebral thrombosis with hemiplegia or monoplegia, are presented. Pentoxifylline appeared to be more effective in reducing motor deficit and was significantly better in improving the patients' intelligence and memory score. Recovery from speech deficit was equally well seen with both drugs.
Get full access to this article
View all access options for this article.
References
1.
ArakiGOtomoE (1976) Clinical efficacy of pentoxifylline (BL 191) and pyrithioxide hydrochloride (PTX) in treatment of cerebrovascular disorders. Clinical Evaluation4, 213.
2.
BuckertDHarwartD (1976) Trials of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in double-blind tests. Il FarmacoXXXI, 264.
3.
EhrlyA M (1976) Improvement of the flow properties of blood: A new therapeutical approach in occlusive arterial disease. Angiology27, 188.
4.
GastparHAmbrusJ LAmbrusC MSpaventoPWeberF JThurberL E (1977) Study of platelet aggregation in vivo III. Effect of Pentoxifylline. Journal of Medicine8, 191.
5.
HayashiSOzawaH (1974) Cyclic 3′,5′-nucleotide phosphodiesterase (PDE) and the inhibitory effect of BL 191 on PDE in rat brain and heart. Chemical and Pharmaceutical Bulletin23, 587.
6.
HessHFrankeIJauchM (1973) Medikamentöse Verbesserung der Fließeigenschaften des Blutes. Fortschritte der Medizin91, 743.
7.
HoneggerH (1973) Untersuchung der zentralen Durchblutung mit Hilfe der Ophthalmodynamographie. Folia Angiologica21, 207.
8.
JovanovićU J (1976) Statistical evaluation of polygraphic investigations of pentoxifylline. Journal of International Medical Research4, 211.
9.
OlesenJPaulsonO B (1971) The effect of intra-arterial papaverine on the regional cerebral blood flow in patients with stroke or intracranial tumor. Stroke2, 148.
10.
SakuraiMKomarekJ (1974) Comparative studies of 3,7-dimethyl-1-(5-oxohexyl)-xanthine and theophylline on cardiac function. Archives of International Pharmacodynamics209, 342.
11.
SchaféM K (1973) Erfahrungen mit Trental bei peripheren Durchblutungsstörungen undzerebrovaskulärer Insuffizienz. Münchener Medizinische Wochenschrift115, 1745.
12.
SchubotzRMühlfellnerO (1977) The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acids distribution in the erythrocyte membrane. Current Medical Research and Opinion4, 609.
13.
WackenheimA (1976) Le traitement de l'insuffisance vertébro-basilaire par le Torental. Médicine Actuelle3, 176.
14.
WhittierJ H (1964) Vasorelaxant drugs and cerebrovascular disease. Angiology15, 82.
